142 related articles for article (PubMed ID: 8918853)
1. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study.
Bresee JS; Mast EE; Coleman PJ; Baron MJ; Schonberger LB; Alter MJ; Jonas MM; Yu MY; Renzi PM; Schneider LC
JAMA; 1996 Nov; 276(19):1563-7. PubMed ID: 8918853
[TBL] [Abstract][Full Text] [Related]
2. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1994 Jul; 43(28):505-9. PubMed ID: 8022396
[TBL] [Abstract][Full Text] [Related]
3. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin.
Jonas MM; Baron MJ; Bresee JS; Schneider LC
Pediatrics; 1996 Aug; 98(2 Pt 1):211-5. PubMed ID: 8692620
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin and hepatitis C virus: the Scandinavian experience.
Björkander J; Fasth A; Widell A
Clin Ther; 1996; 18 Suppl B():73-82. PubMed ID: 8930444
[TBL] [Abstract][Full Text] [Related]
5. An outbreak of acute hepatitis C among recipients of intravenous immunoglobulin.
Flora K; Schiele M; Benner K; Montanaro A; Johnston W; Whitham R; Press R
Ann Allergy Asthma Immunol; 1996 Feb; 76(2):160-2. PubMed ID: 8595535
[TBL] [Abstract][Full Text] [Related]
6. Gammagard and reported hepatitis C virus episodes.
Gomperts ED
Clin Ther; 1996; 18 Suppl B():3-8. PubMed ID: 8930438
[TBL] [Abstract][Full Text] [Related]
7. Transmission of hepatitis C virus in allografted patients: use of viral genotyping as an epidemiological marker.
Gangneux JP; Traineau R; Tuveri R; Ravera N; Bureau C; Gluckman E; Benbunan M; Loiseau P
Bone Marrow Transplant; 1996 Dec; 18(6):1131-3. PubMed ID: 8971383
[TBL] [Abstract][Full Text] [Related]
8. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission.
Berger A; Doerr HW; Scharrer I; Weber B
J Med Virol; 1997 Sep; 53(1):25-30. PubMed ID: 9298728
[TBL] [Abstract][Full Text] [Related]
9. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.
Healey CJ; Sabharwal NK; Daub J; Davidson F; Yap PL; Fleming KA; Chapman RW; Simmonds P; Chapel H
Gastroenterology; 1996 Apr; 110(4):1120-6. PubMed ID: 8613001
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
[TBL] [Abstract][Full Text] [Related]
11. The effect on the safety of intravenous immunoglobulin of testing plasma for antibody to hepatitis C.
Biswas RM; Nedjar S; Wilson LT; Mitchell FD; Snoy PJ; Finlayson JS; Tankersley DL
Transfusion; 1994 Feb; 34(2):100-4. PubMed ID: 7508642
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin.
Bjøro K; Frøland SS; Yun Z; Samdal HH; Haaland T
N Engl J Med; 1994 Dec; 331(24):1607-11. PubMed ID: 7526215
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors.
Shuhart MC; Myerson D; Spurgeon CL; Bevan CA; Sayers MH; McDonald GB
Bone Marrow Transplant; 1996 Apr; 17(4):601-6. PubMed ID: 8722362
[TBL] [Abstract][Full Text] [Related]
14. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.
Kenny-Walsh E
N Engl J Med; 1999 Apr; 340(16):1228-33. PubMed ID: 10210705
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin and hepatitis C virus: an overview of transmission episodes with emphasis on manufacturing data.
Yap PL
Clin Ther; 1996; 18 Suppl B():43-58. PubMed ID: 8930441
[TBL] [Abstract][Full Text] [Related]
17. Cost savings from intravenous immunoglobulin manufactured from chromotography/caprylate (IGIV-C) in persons with primary humoral immunodeficiency disorder.
Mahadevia PJ; Strell J; Kunaprayoon D; Gelfand E
Value Health; 2005; 8(4):488-94. PubMed ID: 16091026
[TBL] [Abstract][Full Text] [Related]
18. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
Ahmad N; Asgher M; Shafique M; Qureshi JA
Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
[TBL] [Abstract][Full Text] [Related]
19. Infection by hepatitis C virus through contaminated intravenous immune globulin: results of a prospective national inquiry in France.
Lefrère JJ; Loiseau P; Martinot-Peignoux M; Mariotti M; Ravera N; Thauvin M; Marcellin P; Janot C
Transfusion; 1996 May; 36(5):394-7. PubMed ID: 8693501
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy.
Mast EE; Hwang LY; Seto DS; Nolte FS; Nainan OV; Wurtzel H; Alter MJ
J Infect Dis; 2005 Dec; 192(11):1880-9. PubMed ID: 16267758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
